NASDAQ : PRLD
Prelude Therapeutics Incorporated — Financial statements
Healthcare · Biotechnology · United States
Last price 4.1 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 422.28M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Prelude Therapeutics Incorporated (PRLD) reported revenue of 22.42M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 22.42M | 12.14M | 7.00M | |||
| Gross Profit | 22.42M | 12.14M | 7.00M | |||
| Selling, General & Admin | 20.29M | 22.31M | 28.72M | 28.88M | 30.65M | 26.96M |
| Research & Development | 68.23M | 93.10M | 118.00M | 103.39M | 92.89M | 86.78M |
| Operating Expenses | 88.52M | 115.41M | 146.71M | 132.28M | 123.54M | 113.73M |
| Operating Income | -66.10M | -103.27M | -139.71M | -132.28M | -123.54M | -113.73M |
| Other Non Operating Income (Expenses) | 6.91M | 5.07M | 12.54M | 10.45M | 8.10M | 2.04M |
| EBT Excluding Unusual Items | -59.19M | -98.20M | -127.17M | -121.83M | -115.44M | -111.69M |
| Merger & Restructuring Charges | -1.30M | -1.30M | ||||
| Pretax Income | -60.49M | -99.50M | -127.17M | -121.83M | -115.44M | -111.69M |
| Net Income | -60.49M | -99.50M | -127.17M | -121.83M | -115.44M | -111.69M |
| Net Income to Common | -60.49M | -99.50M | -127.17M | -121.83M | -115.44M | -111.69M |
| Shares Outstanding (Basic) | 84.21M | 76.96M | 75.81M | 60.36M | 47.37M | 46.05M |
| Shares Outstanding (Diluted) | 84.21M | 76.96M | 75.81M | 60.36M | 47.37M | 46.05M |
| EPS (Basic) | -0.72 | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EPS (Diluted) | -0.72 | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| Free Cash Flow | -33.26M | -56.37M | -103.65M | -110.58M | -86.75M | -85.85M |
| Free Cash Flow Per Share | -0.40 | -0.73 | -1.37 | -1.83 | -1.83 | -1.86 |
| Gross Margin | 100.00% | 100.00% | 100.00% | |||
| Operating Margin | -294.76% | -850.63% | -1,995.91% | |||
| Profit Margin | -269.75% | -819.59% | -1,816.76% | |||
| Free Cash Flow Margin | -148.30% | -464.32% | -1,480.74% | |||
| EBITDA | -64.51M | -101.56M | -137.94M | -131.11M | -122.22M | -112.82M |
| D&A For EBITDA | 1.59M | 1.71M | 1.77M | 1.17M | 1.32M | 915.00K |
| EBIT | -66.10M | -103.27M | -139.71M | -132.28M | -123.54M | -113.73M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.33M | 35.26M | 12.47M | 25.29M | 30.61M | 31.83M |
| Short-Term Investments | 125.43M | 67.96M | 121.14M | 207.64M | 171.12M | 259.40M |
| Cash & Short-Term Investments | 151.76M | 103.21M | 133.61M | 232.94M | 201.73M | 291.23M |
| Prepaid Expenses | 3.14M | 2.48M | 2.28M | 2.65M | 2.65M | 3.88M |
| Total Current Assets | 154.90M | 105.69M | 135.90M | 235.59M | 204.38M | 295.12M |
| Property, Plant & Equipment | 30.79M | 32.28M | 35.47M | 37.74M | 6.70M | 5.64M |
| Other Long-Term Assets | 3.68M | 3.35M | 4.15M | 4.34M | 9.42M | 4.35M |
| Total Assets | 189.36M | 141.31M | 175.51M | 277.67M | 220.50M | 305.10M |
| Accounts Payable | 2.03M | 3.98M | 7.73M | 4.58M | 6.78M | 7.84M |
| Accrued Expenses | 7.35M | 11.57M | 14.44M | 14.82M | 12.57M | 9.53M |
| Current Portion of Leases | 2.78M | 2.74M | 2.70M | 1.48M | 1.83M | 1.74M |
| Current Unearned Revenue | 25.25M | 33.73M | ||||
| Other Current Liabilities | 630.00K | 965.00K | 771.00K | 945.00K | 524.00K | 87.00K |
| Total Current Liabilities | 38.04M | 52.99M | 25.64M | 21.83M | 21.70M | 19.20M |
| Long-Term Leases | 14.87M | 15.04M | 15.32M | 15.41M | ||
| Long-Term Unearned Revenue | 1.80M | |||||
| Other Long-Term Liabilities | 2.72M | 2.84M | 3.09M | 3.34M | 3.36M | |
| Total Liabilities | 55.63M | 72.68M | 44.06M | 40.58M | 25.06M | 19.20M |
| Common Stock | 8.00K | 6.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 841.32M | 751.68M | 714.98M | 693.25M | 531.68M | 505.72M |
| Retained Earnings | -707.37M | -683.06M | -583.56M | -456.39M | -334.56M | -219.12M |
| Comprehensive Income & Other | -227.00K | 8.00K | 35.00K | 223.00K | -1.69M | -711.00K |
| Total Common Equity | 133.73M | 68.64M | 131.46M | 237.09M | 195.44M | 285.90M |
| Shareholders' Equity | 133.73M | 68.64M | 131.46M | 237.09M | 195.44M | 285.90M |
| Total Liabilities & Equity | 189.36M | 141.31M | 175.51M | 277.67M | 220.50M | 305.10M |
| Total Debt | 17.65M | 17.79M | 18.02M | 16.89M | 1.83M | 1.74M |
| Net Cash (Debt) | 134.11M | 85.42M | 115.59M | 216.05M | 199.90M | 289.49M |
| Net Cash Per Share | 1.59 | 1.11 | 1.52 | 3.58 | 4.22 | 6.29 |
| Filing Date Shares Outstanding | 102.99M | 82.53M | 75.99M | 75.73M | 47.71M | 47.02M |
| Total Common Shares Outstanding | 102.95M | 82.49M | 75.98M | 75.72M | 47.70M | 46.99M |
| Working Capital | 116.86M | 52.70M | 110.25M | 213.76M | 182.68M | 275.91M |
| Book Value Per Share | 1.30 | 0.83 | 1.73 | 3.13 | 4.10 | 6.08 |
| Tangible Book Value | 133.73M | 68.64M | 131.46M | 237.09M | 195.44M | 285.90M |
| Tangible Book Value Per Share | 1.30 | 0.83 | 1.73 | 3.13 | 4.10 | 6.08 |
| Machinery | 10.34M | 10.32M | 8.97M | 5.71M | 4.38M | |
| Construction In Progress | 338.00K | 1.64M | 668.00K | |||
| Leasehold Improvements | 1.71M | 1.70M | 1.58M | 875.00K | 875.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -60.49M | -99.50M | -127.17M | -121.83M | -115.44M | -111.69M |
| Depreciation & Amortization | 1.59M | 1.71M | 1.77M | 1.17M | 1.32M | 915.00K |
| Loss (Gain) From Sale of Investments | -938.00K | -371.00K | -4.64M | -3.47M | 2.59M | 1.36M |
| Stock-Based Compensation | 8.29M | 11.91M | 21.34M | 25.62M | 25.14M | 20.93M |
| Other Operating Activities | 1.54M | 1.53M | 1.59M | 1.94M | 1.72M | 1.33M |
| Change in Accounts Payable | -3.19M | -3.92M | 3.31M | -2.27M | -347.00K | 3.90M |
| Change in Unearned Revenue | 25.25M | 35.53M | ||||
| Change in Other Net Operating Assets | -5.31M | -3.21M | 911.00K | -8.21M | 1.28M | -278.00K |
| Operating Cash Flow | -33.26M | -56.30M | -102.89M | -107.06M | -83.73M | -83.53M |
| Capital Expenditures | -67.00K | -764.00K | -3.51M | -3.02M | -2.32M | |
| Investment in Securities | -77.25M | 53.53M | 90.95M | -31.13M | 84.71M | -261.48M |
| Investing Cash Flow | -77.25M | 53.46M | 90.19M | -34.65M | 81.69M | -263.80M |
| Long-Term Debt Repaid | -208.00K | -395.00K | ||||
| Net Debt Issued (Repaid) | -208.00K | -395.00K | ||||
| Issuance of Common Stock | 115.18M | 25.04M | 439.00K | 136.41M | 815.00K | 165.20M |
| Repurchase of Common Stock | -74.00K | -17.00K | -54.00K | -17.00K | ||
| Other Financing Activities | -4.66M | -110.00K | -303.00K | |||
| Financing Cash Flow | 110.44M | 24.82M | -120.00K | 136.40M | 815.00K | 164.90M |
| Net Cash Flow | -62.00K | 21.97M | -12.82M | -5.31M | -1.22M | -182.44M |
| Free Cash Flow | -33.26M | -56.37M | -103.65M | -110.58M | -86.75M | -85.85M |
| Free Cash Flow Margin | -148.30% | -464.32% | -1,480.74% | |||
| Free Cash Flow Per Share | -0.40 | -0.73 | -1.37 | -1.83 | -1.83 | -1.86 |
| Levered Free Cash Flow | -13.84M | -23.87M | -62.00M | -58.93M | -50.12M | -46.86M |
| Unlevered Free Cash Flow | -13.84M | -23.87M | -62.00M | -58.93M | -50.12M | -46.86M |
| Change in Working Capital | 16.75M | 28.41M | 4.22M | -10.48M | 932.00K | 3.62M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 395.50M | 238.95M | 96.73M | 322.85M | 287.43M | 577.35M |
| Enterprise Value | 261.39M | 201.85M | -38.76M | 92.82M | 64.78M | 258.63M |
| Last Close Price | 3.88 | 2.90 | 1.27 | 4.27 | 6.04 | 12.45 |
| PS Ratio | 17.68 | 19.68 | 13.82 | |||
| PB Ratio | 2.99 | 3.48 | 0.74 | 1.36 | 1.47 | 2.02 |
| P/TBV Ratio | 2.97 | 3.48 | 0.74 | 1.36 | 1.47 | 2.02 |
| EV/Sales Ratio | 11.70 | 16.63 | ||||
| Debt / Equity Ratio | 0.13 | 0.26 | 0.14 | 0.07 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.00 | -1.25 | -0.88 | -0.91 | -1.02 | -1.01 |
| Net Debt / EBITDA Ratio | 2.08 | 0.84 | 0.84 | 1.65 | 1.64 | 2.57 |
| Net Debt / FCF Ratio | 4.03 | 1.51 | 1.11 | 1.95 | 2.30 | 3.37 |
| Asset Turnover | 0.15 | 0.08 | 0.03 | |||
| Quick Ratio | 3.99 | 1.95 | 5.21 | 10.67 | 9.29 | 15.17 |
| Current Ratio | 4.07 | 1.99 | 5.30 | 10.79 | 9.42 | 15.37 |
| Return on Equity (ROE) | -57.73% | -99.45% | -69.01% | -56.34% | -47.97% | -44.85% |
| Return on Assets (ROA) | -27.15% | -40.74% | -38.54% | -33.19% | -29.38% | -26.89% |
| Return on Capital Employed (ROCE) | -43.70% | -116.90% | -93.20% | -51.70% | -62.10% | -39.80% |
| Earnings Yield | -18.71% | -41.64% | -131.47% | -37.74% | -40.16% | -19.35% |
| FCF Yield | -8.39% | -23.59% | -107.16% | -34.25% | -30.18% | -14.87% |
| Buyback Yield / Dilution | -10.91% | -1.52% | -25.60% | -27.41% | -2.87% | -269.03% |